Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

Read more

ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved

Read more

Less than 4 weeks until Immuno-Therapy Experts gather at the Immuno-Oncology Conference this September in London

Read more

Pfizer Receives Breakthrough Therapy Designation from FDA for PF-06651600

Read more

AMRI and Metrion Biosciences collaborate to offer ion channel drug discovery services

Read more

FDA Grants Priority Review to Merck’s sBLA for KEYTRUDA (pembrolizumab)

Read more

SGS Successfully Implements PBMC Analysis for Early Phase Clinical Trials

Read more

Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine

Read more

United Therapeutics and MannKind Announce Collaboration for Pulmonary Hypertension Products

Read more

Sanofi reaches civil settlement with US SEC

Read more

Posts pagination

Previous Page 1 of 923 … Page 698 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version